All data are based on the daily closing price as of February 21, 2025
u
Universal Vision Biotechnology
3218.TWO
7.14 USD
0.12
+1.71%
Overview
Last close
7.14 usd
Market cap
605.34M usd
52 week high
10.30 usd
52 week low
5.85 usd
Target price
6.56 usd
Valuation
P/E
18.4107
Forward P/E
N/A
Price/Sales
4.7395
Price/Book Value
5.8524
Enterprise Value
583.85M usd
EV/Revenue
4.5739
EV/EBITDA
10.2543
Key financials
Revenue TTM
127.65M usd
Gross Profit TTM
76.30M usd
EBITDA TTM
51.13M usd
Earnings per Share
0.39 usd
Dividend
0.21 usd
Total assets
183.40M usd
Net debt
N/A usd
About
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers eye plastic and micro cosmetic surgery; and aesthetic medicine consulting services, and provides nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.